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Introduction
Pelvic inflammatory disease (PID) is an infection 
of the upper genital tract (the uterus, fallopian tubes, 
or ovaries), occurring predominantly in sexually active 
young women (Curry et al. 2019). PID includes inflam-
mation of the inner lining of the uterus (endometritis) 
and infection/inflammation of the fallopian tubes (sal-
pingitis). If untreated, PID can cause severe and long-
term complications, including tubal factor infertility 
(TFI), chronic pelvic pain, recurrent PID (Haggerty 
et al. 2016), ectopic pregnancy, and infertility. In addi-
tion, these complications could lead to severe and last-
ing damage to the female reproductive organs (Wang 
et al. 2018). Therefore, early diagnosis and treatment of 
PID are essential in preventing complications (Jennings 
and Krywko 2020). 
In particular, in the United States, acute PID remains 
a  leading gynecologic cause for hospitalization, with 
1  million people diagnosed every year (Walker and 
Wiesenfeld 2007). Approximately 4.1% of sexually active 
young women in the United States receive lifelong PID 
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A b s t r a c t
Human vaginal microorganisms play an important role in maintaining good health throughout the human life cycle. An imbalance in the 
vaginal microbiota is associated with an increased risk of pelvic inflammatory disease (PID). This study aimed to characterize and compare 
vaginal microbial profiles of premenopausal Korean women with and without PID. 74 Korean premenopausal female vaginal samples were 
obtained; 33 were from healthy women (a control group) and 41 from PID patients. Vaginal fluid samples were collected from the vaginal 
wall and posterior cervix and then analyzed by 16S ribosomal ribonucleic acid (rRNA) gene-based amplicon sequencing. Results showed 
a significant difference between the vaginal microbial communities of the two groups (Jensen-Shannon, p = 0.014; Bray-Curtis, p = 0.009; 
Generalized UniFrac, p = 0.007; UniFrac, p = 0.008). Lactobacillus accounted for the highest percentage (61.0%) of the control group but 
was significantly decreased (34.9%) in PID patients; this was the most significant difference among all bacterial communities (p = 0.028, 
LDA effect size = 5.129). In addition, in the PID patient group, species diversity significantly increased (Simpson, p = 0.07) as the proportion 
of various pathogens increased evenly, resulting in a polymicrobial infection. Similarly, lactate, which constituted the highest percentage 
of the organic acids in the control group, was significantly decreased in the PID patient group (p = 0.04). The present study’s findings will 
help understand PID from the microbiome perspective and are expected to contribute to the development of more efficient PID diagnosis 
and treatment modalities. 
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treatment, and approximately 40% of PID diagnoses 
have symptoms, and 10–20% of cases complicate to 
infertility or ectopic pregnancy (Reekie et al. 2018)
The etiology of PID is mainly associated with sexu-
ally transmitted microorganisms such as Chlamydia 
trachomatis, Neisseria gonorrhoeae, Mycoplasma geni-
talium, and Gram-negative bacteria (Revzin et al. 2016); 
however, other cervical, enteric, bacterial vaginosis-
associated, and respiratory pathogens, including Myco-
bacterium tuberculosis, may be involved (Curry et al. 
2019). In virgin women, PID is rare, and it is hypoth-
esized that lower genital, urinary tract, gastrointestinal 
tract, and skin wounds are the sites of origin for PID, 
from which the infection spreads directly or ascends 
through the lower genital tract to the upper genital 
tract (Cho et al. 2017). In addition, vaginal micro-
organisms consistent with bacterial vaginosis (BV) are 
also known risk factors for upper genital tract infec-
tious diseases like PID in gynecological and obstetric 
patients (Sharma et al. 2014; Graspeuntner et al. 2018). 
Diagnosis and management of PID are challeng-
ing because of the varying signs and symptoms and 
a  polymicrobial etiology. Therefore, broad-spectrum 
antimicrobial agents have been mainly used for treat-
ment. Unfortunately, this empirical treatment results 
in antibiotic resistance and side effects such as allergic 
reactions and bowel disease (Gradison 2012). Thus, the 
treatment of women with acute PID hinges on recogniz-
ing the polymicrobial etiology of the infectious process 
(Walker and Wiesenfeld 2007). However, classical meth-
ods of culturing pathogens or detecting the nucleic acids 
of pathogens in PID patients cannot distribute all the 
microbes in the environment (Graspeuntner et al. 2018).
Molecular methods such as next-generation sequen c - 
 ing (NGS) are actively employed to characterize human 
microbiota in patients and healthy individuals (Vir-
tanen et al. 2017). In particular, the meta-genomics 
method based on 16S RNA has recently gained popu-
larity owing to its ability to detect unculturable micro-
organisms and analyze whole microorganisms in the 
environment (Wang et al. 2018). This change has ena-
bled analysis of a wide range of intravaginal micro-
biomes, infections, and diseases (Fettweis et al. 2012), 
including vaginal microbiome (Ravel et al. 2011), bacte-
rial vaginitis (BV) (Srinivasan et al. 2012), PID (Wang 
et al. 2018), and changes in vaginal microbial distri-
bution during pregnancy and the postpartum period 
(MacIntyre et al. 2015).
Female genital tract microbiota plays a crucial role 
in maintaining health, and an imbalance of the micro-
biota has been associated with an increased risk of pel-
vic infections. In addition, the microbial environment 
of the vagina differs between races, suggesting that 
vaginal microbiome analysis should be done by race 
(Fettweis et al. 2014).
Here, we performed an NGS-based microbiome 
analysis of the vaginal microbiome for Korean premen-
opausal PID patients and healthy women, and reported 
the results of the profiling analysis.
Experimental
Materials and Methods
Patients and sample collection. A sampling of 
female vaginal fluid was done from January 2020 to 
February 2020 in the Gynecology Department of Soon-
chunhyang University Cheonan Hospital affiliated with 
the Probiotics Microbiome Convergence Center in 
Soonchunhyang University, Korea. The sampling was 
approved by the Ethics Committee of Soonchunhyang 
University Cheonan Hospital (eIRB) (IRB No. 2019-10-
017-005). A total of 74 premenopausal women aged 
18 to 50 years were enrolled in this study: 41 premeno-
pausal PID patients and 33 premenopausal normal con-
trol women. The diagnosis was made clinically based 
on the CDC PID diagnostic criteria (Crossman 2006). 
All participants were informed of sampling procedures 
and risks. They agreed with all laboratory tests and were 
provided with written informed consent. Samples of 
PID patients were collected when abnormal vaginal dis-
charge was reported regardless of fertility, body mass 
index (BMI), underlying disease, or gynecologic dis-
ease. Abnormal vaginal discharge was considered when 
a patient described a discharge with abnormal color or 
appearance, foul odor, itching, and burning that neces-
sitated examination and treatment. Vaginal swabs were 
collected by gently rubbing the entire vaginal wall and 
posterior cervix using a 10 cm long cotton swab with 
sterile normal saline and a cotton swab provided by the 
commercial STD (sexually transmitted disease) poly-
merase chain reaction (PCR) and culture kit. The sam-
pling was done in an independent space by one female 
gynecologist after confirming patients eligible for PID 
screening (Table I). Samples of normal control women 
were collected in the same way after confirming that 
they did not fit the criteria of PID. All samples were 
collected at room temperature. They were immediately 
transferred in a sterile normal saline container provided 
by the STD PCR kit and culture kit and then sent to the 
laboratory immediately for microbiome analysis.
Microbe detection using STD multiplex real-time 
PCR and culture methods. Real-time PCR was per-
formed to detect eight STD-related microorganisms: 
Mycoplasma hominis, Ureaplasma parvum, Ureaplasma 
urealyticum, Gardnerella vaginalis, C. trachomatis, 
N. gonor rhoeae, Trichomonas vaginalis, and Candida 
albicans. Nucleic acid was extracted from the vaginal 
fluid using a MagNA Pure 96 (Roche Diagnostics, 
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Germany). Multiplex real-time PCR was performed 
on a CFX96 real-time PCR detection system (CFX96; 
Bio-Rad, USA) using the following PCR conditions: 
primary denaturation at 95°C for 15 minutes; 50 cycles 
of denaturation at 95°C for 30  seconds, annealing at 
60°C for 1 minute, and extension at 72°C for 30 sec-
onds; final cooling down at 55°C for 30 seconds. Then, 
STD diagnosis was performed as previously reported 
and interpreted as positive or negative (Kriesel et al. 
2016). Microorganisms were also cultured for conven-
tional identification using a sterile transport swab with 
agar gel (COPAN, Brescia, Italy). Only cultures with 
a growth of ≥ 1.5 × 103 colony-forming unit (CFU)/ml 
were considered positive.
PCR amplification of 16S rRNA genes. 1 ml of 
vaginal secretion diluted with saline solution was 
transferred in a Lysing Matrix B tube with 0.1-mm-
diameter glass beads (MP Biomedicals, USA). Bead 
beating was carried out using a FastPrep-24 5G instru-
ment (MP Biomedicals, USA) at a speed of 6.0 m/s for 
30 seconds. The V4 region of the 16S rRNA gene was 
amplified using primers containing overhang sequences 
compatible with the Illumina Nextera XT index. The 
forward primer sequence was 515F (5’-TCGTCG-
GCAGCGTCAGATGTGTATAAGAGACAGGTGC-
CAGCMGCCGCGGTAA-3’), and the reverse was 806R 
(5’-GTCTCGTGGGCTCGGAGATGTGTATAAGA-
GACAGGGACTACHVGGGTWTCTAAT-3’). Among 
the 515F and 806R primer sequences, the first 33 and 
34 sequences are overhang sequences, and the sequences 
connected by dashes are V4 locus-specific sequences. 
Moreover, this primer set was designed to specifically 
amplify from 515 bp to 806 bp of the 16S rRNA gene. 
Accordingly, the expected size of the PCR product was 
confirmed by gel electrophoresis as 359 bp, and in the 
case of the template-free control, it was confirmed that 
the target sequence was not amplified after PCR. All 
PCR reactions were carried out using a 2X KAPA HiFi 
HotStart ReadyMix (Kapa Biosystems, USA). The final 
volume of each sample was 25 µl; 12.5 µl of 2X KAPA 
HiFi HotStart ReadyMix reagent, 5 µl of each primer at 
a concentration of 1 µM, and 2.5 µl (5 ng/µl) of template 
DNA. Reactions were run with the following cycling 
parameters: initial denaturation at 95°C for 3 min; 
25 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 30 s; 
and a final extension at 72°C for 5 min.
PCR product clean up. A PCR plate was centri-
fuged at 1,000 g for 1 minute at 20°C to collect con-
densation. AMPure XP beads (Beckman Coulter, High 
Wycombe, UK) were vortexed for 30 seconds, and 20 µl 
of them was added to each PCR plate well. The entire 
volume was gently pipetted up and down ten times, 
followed by incubation at room temperature for 5 min-
utes. Next, the PCR plate was placed on a magnetic 
stand for 2 minutes. With the amplicon PCR plate on 
the magnetic stand, supernatants were removed using 
a multichannel pipette, and beads were washed twice 
with freshly prepared 80% ethanol. Then the beads were 
air-dried for 10 minutes, the amplicon PCR plate was 
removed from the magnetic stand, and 52.5 µl of 10 mM 
Tris (pH 8.5) was added to each well of the amplicon 
PCR plate. After the mixture was gently pipetted up 
and down ten times, beads were fully resuspended. The 
plate was incubated at room temperature for 2 minutes 
and then placed on the magnetic stand for 2 minutes. 
Using a multichannel pipette, 50 µl of the supernatant 
was transferred from the amplicon PCR plate to a new 
96-well PCR plate.
Index PCR using 16S amplicons for library con-
struction. According to the manufacturer’s protocol, 
the amplicon library was prepared using Nextera XT 
DNA Library Prep Kit (Illumina, USA). First, 5 µl of 
DNA, Nextera XT Index Primer 1 (N7xx), Nextera XT 
Index Primer 2 (S5xx), 25 µl of 2X KAPA HiFi HotStart 
ReadyMix (KAPA Biosystems, USA), and 10 µl of PCR 
Grade water were mixed by pipetting. Then, a PCR was 
conducted using the following program: initial dena-
turation at 95°C for 30 s; 8 cycles of 95°C for 30 s, 55°C 
for 30 s, 72°C for 30 s; and a final extension step at 72°C 
for 5 min. Lastly, each pool was cleaned.
Sequencing and data analysis. The sample was 
diluted from 1 nM to 50 pM with 10 mM Tris (pH 8.5). 
    Foul odor (Fish and rotten) 25 61.0
PID patients 35.5 ± 2.4 3.3 ± 0.2 29.5 ± 6.9
 Itching and burning sensation 11 26.8
    Abnormal color of discharge 5 12.2
    Total 41 100
Control group 39.4 ± 3.2 3.1 ± 0.2 30.1 ± 4.3
 No observable abnormality 33 100
    Total 33 100
Table I
Clinical profiles of PID patients (n = 41) and women from control group (n = 33).
SD – standard deviation




(mean ± SD) Symptom
Number
of women %
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After adding a 10% PhiX Control library (Illumina, 
USA), the library was then loaded onto an iSeq-100 
reagent cartridge (Illumina, USA) and sequenced on an 
iSeq-100 platform (Illumina, USA) to generate 300 bp 
paired-end reads. Sequencing data were analyzed 
using the EzBioCloud server (http://www.ezbiocloud.
net). Raw read processing began with quality check-
ing, and filtering of low-quality (< Q25) reads in the 
Trimmomatic (version. 0.32) (Bolger et al. 2014). After 
passing quality check (QC), paired-end sequence data 
were merged using the fastq_mergepairs command in 
VSEARCH (version 2.13.4) with default parameters 
(Rognes et al. 2016). The primers were then trimmed 
to a similarity cutoff of 0.8 using Myers and Miller’s 
alignment algorithm (Myers and Miller 1988). Ampli-
cons not encoding 16S rRNA were detected by nhmmer 
in the HMMER software (package ver. 3.2.1) (Wheeler 
and Eddy 2013). After the unique reads were extracted, 
the redundant reads were clustered with the unique 
reads by VSEARCH’s derep_fulllength command 
(Rognes et al. 2016). EzBioCloud’s 16S rRNA database 
(Yoon et al. 2017) was used for a taxonomic assignment 
using VSEARCH’s userarch_global command (Rognes 
et al. 2016), followed by more precise pairwise alignment 
(Myers and Miller 1988). Next, chimeric reads were 
filtered from reads with < 97% similarity by reference-
based chimera detection using the UCHIME algorithm 
(Edgar et al. 2011), and the EzBioCloud’s non-chimeric 
16S rRNA database. After chimera filtering, reads not 
identified at the species level in the EzBioCloud database 
were compiled, then de-novo clustering was performed 
using the cluster_fast command (Rognes et al. 2016) to 
generate additional OTUs. Moreover, OTUs with sin-
gle reads were excluded from further analysis. The 16S 
rRNA amplicon sequences were deposited in Sequence 
Read Archive (SRA) database with accession number 
(BioProject ID: PRJNA745060). The SRA is accessible at 
https://www.ncbi.nlm.nih.gov/bioproject/745060.
Metabolomics analysis. Vaginal samples were 
eluted from swabs using methanol and subjected to 
targeted liquid chromatography (LC) mass spectrom-
etry (MS)‐based metabolomics, as previously described 
(Yuan et al. 2012). Briefly, an LC-MS analysis was per-
formed using Exion LC AD coupled with the X500B 
QTOF system (AB Sciex Pte. Ltd, USA). Samples were 
injected into an ACQUITY UPLC BEH HILIC column 
(2.1 × 50 mm, 1.7 µm). The mobile phase comprised 
phase A (water with 10 mM ammonium formate) and 
phase B (methanol). At the same time, to ensure the 
accuracy of mass detection, auto-calibration was per-
formed every five injections.
Statistical analysis. Alpha diversity indices were 
analyzed based on ACE (Chao and Lee 1992), Chao1 
(Chao 1987), Jackknife (Burnham and Overton 
1979), Shannon/ Simpson (Magurran 2013), NPShan-
non (Chao and Shen 2003), and Phylogenetic diver-
sity (Faith 1992). Beta diversity distances based on 
Jenson-Shannon (Lin 1991), Bray-Curtis (Beals 1984), 
Generalized UniFrac (Chen et al. 2012), and Fast Uni-
Frac (Hamady et al. 2010) were analyzed. Using func-
tional profiles predicted by the PICRUSt (Ye and Doak 
2009) and MinPath (Langille et al. 2013) algorithms, 
taxonomic and functional biomarkers were found by 
statistical comparison algorithms of the LEfSe (Segata 
et al. 2011) and Kruskal-Wallis H tests (Wallis 1952). 
The Student’s t-test was performed to evaluate the sta-
tistical significance in comparing metabolite concentra-
tions between groups.
Results
STD multiplex real-time PCR and culture method 
for PID patients. By STD multiplex real-time PCR, 38 
(92.7%) of the 41 subjects tested positive for at least 
one microorganism (Table  II). The most prevalent 
pathogens were U. urealyticum (24.4%, n = 10/41) and 
U. parvum (24.4%, n = 10/41), followed by M. hominis 
(22.0%, n = 9/41), C. trachomatis (14.6%, n = 6/41), 
N. gonorrhoeae (2.4%, n = 1/41), and T. vaginalis (2.4%, 
n = 1/41). In the culture method, Staphylococcus aureus, 
Streptococcus pyogens, Pseudomonas koreensis, C. albi-
cans, Escherichia coli, and Pseudomonas putida were 
detected in 9 patients (21.9%, n = 9/41).
Microbial diversity in vaginal metagenomes of 
normal women and PID patients. Table III shows the 
average taxonomic compositions at the phylum, class, 
order, and family levels for the control group and the 
PID patient group. At the phylum level, Firmicutes 
accounted for the highest percentage, followed by Act-
inobacteria, Proteobacteria, Bacteroides, and Fuso-
bacteria; the composition for each phylum was 79.4%, 
13.0%, 4.6%, and 1.4% for the control group and 56.9%, 
23.2%, 12.8%, 4.7%, and 2.4% for the PID patient group, 
respectively. Actinobacteria was significantly decreased 
in the PID patient group compared to the control group, 
while the other four Firmicutes phylum were signifi-
cantly increased in the PID patient group compared 
to the control group. Bacilli, which correspond to Fir-
micutes phylum, accounted for the highest percentage 
at the class level, and it was significantly decreased in 
the PID patient group (53.7%) compared to the control 
group (77.7%). In addition, the percentage of Tissierel-
lia of the same phylum was slightly higher in the PID 
patient group than in the control group; 1.0% and 1.5%, 
respectively. Other classes were slightly increased in the 
patient group compared to the control group. Lacto-
bacillaceae occupied the highest percentage at the fam-
ily level and was 27.9% less in the control group than 
in the PID patient group; 63.7% and 35.8%. Apart from 
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the Bacilli and Lactobacillales, the percentage of all 
the other orders was slightly higher in the PID patient 
group than in the control group. Lactobacillaceae occu-
pied the highest percentage at the family level and was 
27.9% less in the control group than in the PID patient 
group; 63.7% and 35.8%, respectively. Streptococcaceae 
 1 + – – + – – – – –
 2 + + – + + – – – –
 3 – – + + – – – – –
 4 – + – + – – – – –
 5 – – + + – – – – –
 6 – + – + – – – – –
 7 – – + + – – – – –
 8 + + – + + + – – –
 9 – – – + + – + – –
10 – – + + – – – – –
11 + + – + + – – – –
12 + – + + – – – – Staphylococcus aureus
13 – – – – – – – – Streptococcus pyogens
14 – – – – – – – + –
15 + + – + – – – – Pseudomonas koreensis
16 + – + + + – – – –
17 – – – + – – – – –
18 – – – – – – – – –
19 – – – – – – – + –
20 – + – + – – – – –
21 + – – + – – – – –
22 – – – – – – – + Candida albicans
23 – – – + – – – – Escherichia coli
24 – – + + – – – – –
25 – + – + + – – – –
26 – – – + – – – – –
27 – – – + – – – – –
28 – – – – – – – + Candida albicans
29 – – – – – – – – –
30 – – – + – – – – Pseudomonas putida
31 – – – – – – – + Candida albicans
32 – – + + – – – – –
33 + + – + – – – – –
34 – – – + – – – – Escherichia coli
35 – – + + – – – – –
36 – – – + – – – – –
37 – – – + – – – – –
38 – – – + – – – – –
39 – + – + – – – – –
40 – – – + – – – – –
41 – – + + – – – – –
Table II
Identification of microbes using STD multiplex PCR and culture method for PID patients.
MH – Mycoplasma hominis, UP – Ureaplasma parvum, UU – Ureaplasma urealyticum,
GV – Gardnerella vaginalis, CT – Chlmamydia trachomatis, NG – Neisseria gonorrhea,




MH UP UU GV CT NG TV CA
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was decreased in the PID group compared to the con-
trol group; 2.6% and 0%, respectively. Contrary to the 
Lactobacillaceae, the percentage of Enterococcaceae in 
the same order was higher in the PID patient group 
than in the control group; 8.1% and 13.4%, respectively. 
For all the families apart from those in the Lactobacil-
lales order, the percentages of the PID patient group 
were similar or higher than those of the control group 
except for the Moraxellaceae family.
The average taxonomic compositions at the genus 
level are shown in Fig. 1. In the control women group, 
Lactobacillus accounted for the highest percentage 
(61.0%), followed by Gardnerella (8.4%), Enterococ-
cus (7.7%), Staphylococcus (3.0%), Lactobacillaceae_uc 
(2.7%), Streptococcus (2.6%), Acinetobacter (2.3%), 
Atopobium (2.2%), Prevotella (1.2%), Sneathia (1.2%), 
and Bifidobacterium (1.1%). In the PID patient group, 
Lactobacillus (34.9%), Lactobacillaceae_uc (0%), Acine-
tobacter (2.3%), and Staphylococcus (2.9%) were signifi-
cantly decreased compared to the control group. On the 
other hand, Gardnerella (13.9%), Enterococcus (13.1%), 
Atopobium (6.0%), Prevotella (3.4%), Sneathia (2.2%), 
and Bifidobacterium (1.5%) were increased in the PID 
patient group compared to the control group. Specifi-
cally, Escherichia and Herbaspirillum were not found in 
the control group but were identified in PID patients; 
9.7% and 1.3%, respectively. In addition, the sum of 
the proportions of genera with a distribution of less 
than 1% was 6.6% in the control group but significantly 
higher in the PID patient group and equal to 12.0%.
Correlation between normal control women and 
PID patients. In the control group, microbial richness 
tended to be higher than in the PID patient group, but 
the difference was not statistically significant (Ace, 
p = 0.274; Chao1, p = 0.289; Jackknife, p = 0.267; No. of 
identified species, p = 0.299) (Fig. 2). As for microbial 
diversity, the Simpson index was significantly decreased 
in the PID patient group compared to the control 
group, but there was no significant difference in the 
NPShannon, Shannon, and phylogenetic diversity indi-
ces (NPShanon, p = 0.251; Shannon, p = 0.091; Simpson, 
p = 0.007; Phylogenetic diversity, p = 0.373) (Fig. 3). 
The difference in bacterial communities between the 
healthy women and PID patients was also analyzed 
using the principal coordinate analysis (PCoA) plots 
based on Jensen-Shannon divergence, Bray-Curtis, 
         Lactobacillaceae 63.7 35.8
      Lactobacillales 74.5 50.2 Enterococcaceae 8.1 13.4
Firmicutes 79.4 56.9 Bacilli 77.7 53.7    Streptococcaceae 2.6 0
      Bacillales 3.1 3.4 Staphylococcaceae 3.1 3.1
   Tissierellia 1.0 1.5 Tissierellales 1.0 1.5 Peptoniphilaceae 1.0 1.5
Actinobacteria 13.0 23.2
 Actinobacteria 10.7 16.7 Bifidobacteriales 9.8 15.8 Bifidobacteriaceae 9.8 15.8
   Coriobacteriia 2.3 6.6 Coriobacteriales 2.3 6.6 Coriobacteriaceae 2.3 6.6
   
Gammaproteobacteria 4.1 11.0
 Pseudomonadales 2.7 1.5 Moraxellaceae 2.4 0
Proteobacteria 4.6 12.8    Enterobacterales 1.4 9.4 Enterobacteriaceae 0 9.2
   Betaproteobacteria 0 1.6 Burkholderiales 0 1.6 Oxalobacteraceae 0 1.3
Bacteroidetes 1.4 4.7 Bacteroidia 1.3 4.6 Bacteroidales 1.3 4.6 Prevotellaceae 1.2 3.7
Fusobacteria 1.2 2.4 Fusobacteria 1.2 2.4 Fusobacteriales 1.2 2.4 Leptotrichiaceae 1.2 2.2
Table III
Distributions of bacterial community at different taxonomic levels (phylum, class, order, and family).
Unit – %, those with less than 1% share are not included
Phylum Con. PID Class Order Con. PID Family Con. PIDCon. PID
Fig. 1. Genus-level vaginal microbiome compositions in women of control group and PID patients.
Data for minor orders with a relative abundance < 1% are not shown.
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Fig. 3. Boxplot of Species diversity indices.
NP Shannon (p = 0.251), Shannon (p = 0.091), Simpson (p = 0.007), Phylogenetic diversity (p = 0.373) reflect the diversity of OTU in samples.
Bars indicate the median, and the hinges represent the lower and upper quartiles. The Wilcoxon rank-sum test was used
to determine the diversity index. *p < 0.05; **p < 0.01
Fig. 2. Boxplot of Species richness indices.
A) Ace (p = 0.274), B) Chao1 (p = 0.289), C) Jackknife (p = 0.267) indices and D) The number of OTUs (p = 0.299) reflects the diversity of OTU
in samples. Bars indicate the median, and the hinges represent the lower and upper quartiles. In panels (A-D), no statistically significant differences
were observed between the normal control women and PID patients. The Wilcoxon rank-sum test was used to determine the species richness.
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Generalized UniFrac, UniFrac and presented in two 
and three dimensions, respectively (Fig. 4A and 4B). 
The microbiome PCoA in the vagina shows that most 
vaginal samples from PID patients (light green/red) 
are placed in the lower right region of the ordination, 
whereas most vaginal samples from normal women 
(blue/purple) are placed in the upper left region. Beta 
set-significance analysis showed significant differences 
in genera or species between the PID patients and the 
control women group (Fig. 4C). This result indicates 
that PID characterizes women’s microbiome composi-
tion. Cluster analysis based on Unweighted Pair Group 
Method with Arithmetic means (UPGMA) hierarchi-
cal clustering analysis also showed that vaginal samples 
from PID patients and normal women were grouped 
separately (Fig. 5). Samples from the same group 
showed that they were usually clustered together.
Taxonomic biomarker discovery. Based on Kruskal- 
-Wallis H test results, there were significant differences 
in two phyla, two classes, three orders, six families, and 
11 genera (Table IV). Firmicutes phylum, Bacilli class, 
Lactobacillales order, Lactobacillaceae family, Moraxel-
laceae family, Lactobacillaceae_uc genus, Gardnerella 
genus, and Lactobacillus genus had a distribution of 
more than 1% in control and PID patient groups. The 
distributions of Firmicutes phylum (control, 79.38%; 
PID, 56.87%), Bacilli class (control, 77.74%; PID, 
53.65%), Lactobacillales order (control, 74.52%; PID, 
50.17%), Lactobacillaceae family (control, 63.70%; PID, 
35.76%), Lactobacillaceae_uc genus (control, 2.67%; 
PID, 0.84%), Lactobacillus genus (control, 61.03%; PID, 
34.92%), and Moraxellaceae family (control, 2.40%; 
PID, 0.68%) were decreased in the PID patient group 
compared to the control group. On the contrary, the 
distributions of Gardnerella genus (control, 8.36%; PID, 
13.89%) were higher in the PID patient group than in 
the control group. The taxons with linear discriminant 
analysis (LDA) effect size exceeding five included Fir-
micutes (5.09916), Bacilli (5.12693), Lactobacillales 
(5.13602), Lactobacillaceae (5.15948), and Lactobacil-
lus (5.12933) (Fig. 6). For the Moraxellaceae family 
(4.05126) and Gardnerella genus (4.54975), the LDA 
effect size was greater than 4 and less than 5.
Vaginal organic acids by metabolomics analysis. 
Fig. 6 shows the quantitative analysis results for organic 
acids. In the control group, lactate concentration was 
the highest; 98.3% of the total organic acid content 
was analyzed, followed by pyruvate, 4-hydroxyphe-
nylacetate, 2-hydroxylsovalerat, succinate, benzoate, 
isovalerate, butyrate, and malonate. In particular, the 
lactate concentration in the PID patient group was 
93.5%, which was significantly reduced compared to 
the control group (p = 0.04), while pyruvate, isovalerate, 
and malonate were slightly decreased in the PID patient 
group compared to the control group. 4-hydroxyphe-
nylacetate (p = 0.0063) and 2-hydroxylsovalerate were 
significantly increased (p = 0.0015) in the PID patient 
group compared to the control group, while succinate, 
benzoate, and butyrate were slightly increased in the 
PID patient group compared to the control group.
Fig. 4. Beta diversity of microbial communities based
on Jensen-Shannon divergence, Bray-Curtis,
Generalized UniFrac, and UniFrac.
A) PCoA plots were produced as an ellipse in two dimensions based on 
a  95% confidence interval. B) PCoA plots were also presented in 3D. 
The blue/purple color indicates normal control women, and the light 
green/red color indicates PID patients, respectively. C) Permutational 
multivariate analysis of variance (PERMANOVA) results demonstrated 
the beta set-significance between the PID patient and normal control 
women groups. **p < 0.01.
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Fig. 5. Clustering using
the Unweighted Pair Group Method
with Arithmetic mean (UPGMA).
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Discussion
Sequencing-based metagenomics research on the 
human microbiome has seen a marked increase since 
the launch of the Human Microbiome Project by the US 
National Institute of Health in 2008 (Turnbaugh et al. 
2007). Metagenomics is now a widely used technique 
that has revolutionized the study of the microbiota 
owing to its ability to generate a comprehensive cata-
log of microbial sequences in a wide range of ecological 
niches within large hosts such as humans (Martin et al. 
2014). Its application has been reported by numerous 
published scientific studies (Callahan et al. 2019) and 
meta-analyses (White et al. 2011).
Phylum
 Firmicutes 0.04364 5.09916 79.38 56.87
 Saccharibacteria_TM7 0.02254 3.25735 0.42 0.02
Class
 Bacilli 0.04089 5.12693 77.74 53.65
 Saccharimonas_c 0.02254 3.21094 0.42 0.02
 Lactobacillales 0.04089 5.13602 74.52 50.17
Order Saccharimonas_o 0.02254 3.24345 0.42 0.02
 Propionibacteriales 0.00628 2.90945 0.24 0.13
 Lactobacillaceae 0.01377 5.15948 63.70 35.76
 Moraxellaceae 0.04593 4.05126 2.40 0.68
Family
 Pseudomonadaceae 0.00272 3.56834 0.28 0.83
 Saccharimonas_f 0.02254 3.23883 0.42 0.02
 Propionibacteriaceae 0.00628 2.91443 0.24 0.12
 Yersiniaceae 0.04997 2.84709 0.06 0.16
 Lactobacillus 0.02881 5.12933 61.03 34.92
 Gardnerella 0.02706 4.54975 8.36 13.89
 Lactobacillaceae_uc 0.00128 3.98329 2.67 0.84
 Pseudomonas 0.00272 3.54428 0.28 0.83
 Parvimonas 0.00445 3.31257 0.00 0.50
Genus Enterobacteriaceae_uc 0.01355 3.29397 0.15 0.50
 AF125206_g 0.02254 3.25111 0.42 0.02
 Megasphaera 0.03362 3.04489 0.14 0.37
 Yersinia 0.04997 2.85166 0.06 0.16
 Cutibacterium 0.01311 2.85157 0.19 0.11
 Actinotignum 0.02287 2.50200 0.06 0.00
Table IV
The Kruskal-Wallis H tests and LEfSe analysis of the associations between normal control women
and PID patients.
Only those with a p-value less than 0.05 were summarized
% refers to the percentage of distribution for each group
LDA – linear discriminant analysis
Taxon







Fig. 6. Taxonomic abundance with an LDA effect size of more than 5.
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Since genital tract microbiota plays a crucial role 
in maintaining health, profiling the entire vaginal 
microbiota in disease states is essential for diagnosis 
(Ravel et al. 2011). However, conventional diagnostic 
methods can detect only a few specific pathogens and 
analyze a small fraction of the entire microbial com-
munity (Li et al. 2019). In our present study, there were 
cases in which patients with clinically diagnosed PID 
did not match the positive results of certain sexually 
transmitted microorganisms. In addition, PID manage-
ment is a challenge since some treatments exhibit their 
therapeutic effects by inhibiting these specific patho-
gens, therefore not being suitable for the treatment of 
the underlying cause of PID (Taylor et al. 2011). To 
overcome PID diagnosis and treatment challenges, we 
performed a vaginal 16S rRNA amplicon sequencing 
analysis for the whole vaginal microbial community in 
PID patients and normal control women.
Our beta diversity analysis results showed a sta-
tistically significant difference between the control 
and the PID patient groups. This difference could be 
attributed to many Lactobacillus in the control group 
and significantly fewer Lactobacillus in the PID patient 
group. Lactobacillus dominates and maintains vaginal 
health through several mechanisms, including inhibit-
ing pathogens, and it is believed that such a significant 
decrease in Lactobacillus leads to opportunistic infec-
tions and overgrowth of various pathogens (Witkin and 
Linhares 2017). This theory explains the difference in 
species diversity in the present study, consequently 
resulting in a polymicrobial infection. Our findings 
are consistent with a previous report of varying spe-
cies diversity between healthy women and PID patients 
due to infection by different pathogens in PID patients 
(Sharma et al. 2014).
In the control group, Lactobacillus dominated, but 
the species richness showed a similar trend to that of 
the PID group. This result probably occurred because 
Lactobacillus, which has antibacterial activity, is domi-
nant, and various pathogenic microorganisms are 
inhibited and colonized at a very low density. Therefore, 
if the balance of the vaginal microbiome is disrupted by 
prolonged antibiotic treatment, Lactobacillus decreases, 
leading to pathogen overgrowth, consequently causing 
disease (Eade et al. 2012). This phenomenon highlights 
the challenges of PID antibiotic therapy. Conventional 
antibiotics that inhibit only specific microorganisms 
destroy normal microbial communities, resulting in 
other diseases (Larsen and Monif 2001). The Lactoba-
cillus treatment has been recently proposed as an alter-
native to conventional antibiotics; they may restore the 
disrupted vaginal flora. This principle is consistent with 
our present study analysis results (Reid et al. 2001).
In the vagina, Lactobacillus produces lactic acid, 
an essential antibacterial substance, and maintains 
a  microbiota while suppressing microorganisms that 
cause dysbiosis (Tachedjian et al. 2017). In the pre-
sent study, we confirmed that lactic acid constituted 
a very high proportion of the organic acids in the con-
trol group, explaining the low number of pathogens in 
the control group compared to that of the PID patient 
group. Based on these findings, it is suggested that 
Lactobacillus and lactic acid concentration could be 
essential factors in diagnosing and treating PID.
There is a strong positive correlation between PID 
and STD-related pathogens, and these pathogens play 
a  vital role in the balance of the microbiome in the 
vagina (Loeper et al. 2018). The vaginal microbiome 
is highly associated with vaginal infections other than 
PID, including bacterial vaginosis, vulvar candidiasis, 
sexually transmitted diseases, and human immuno-
deficiency virus (HIV) infection (van de Wijgert 2017; 
Eastment and McClelland 2018). Furthermore, changes 
in the vaginal microbiota can lead to severe gyneco-
logical problems such as pregnancy loss, preterm labor, 
and low conception rates (Bracewell-Milnes et al. 2018). 
The present study’s findings will help understand PID 
from the microbiome perspective and are expected to 
contribute to the development of more efficient PID 
diagnosis and treatment modalities. In addition, these 
findings are expected to expand the understanding of 
a wide range of gynecological diseases. However, con-
sidering the limitation that only the distribution anal-
ysis of vaginal bacteria was performed in this study, 
additional studies on fungi and viruses should be con-
ducted to understand more relationships between the 
vaginal ecosystem and PID. Understanding the distri-
bution of microorganisms, metabolites, gene expression 
analysis, and their overall correlation is also required.
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